Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 3
This trial is for people with advanced non small cell lung cancer (NSCLC). Advanced NSCLC can mean one of the following:
the cancer is in both lungs
the cancer has spread outside of the lungs into the surrounding area, or elsewhere in the body
there is a collection of fluid around the lung (pleural effusion) and this fluid contains cancer cells
It is for people who are going to have treatment for advanced NSCLC for the first time.
Recruitment start: 28 June 2019
Recruitment end: 29 January 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Samreen Ahmed
Merck Sharp & Dohme Ltd
Eisai
Last reviewed: 1 February 2021
CRUK internal database number: 16221